Quality & Batch Information
The nasal route delivers BPC directly into the bloodstream and supports the brain at the same time
The inclusion of TB-500 and GHK-Cu further supports investigation into peptide interaction dynamics, extracellular matrix-associated processes, and coordinated signaling behavior within laboratory research systems
Sehgal P, Gupta R, Choudhary K, Singh R BPC 157: A Promising Candidate for Cytoprotection and Tissue Repair
GHK-Cu peptide therapy represents one of those solutions, backed by solid mechanistic science and decades of research, that mainstream medicine ignores because theres no patent profit in a naturally occurring peptide
Separate-Vial Reconstitution Spec BAC water added BPC-157 (10 mg vial) 2.0 mL TB-500 (10 mg vial) 2.0 mL Spec Final concentration BPC-157 (10 mg vial) 5.0 mg/mL TB-500 (10 mg vial) 5.0 mg/mL Spec 10 units (0.10 mL) delivers BPC-157 (10 mg vial) 500 mcg TB-500 (10 mg vial) 500 mcg Spec 20 units (0.20 mL) delivers BPC-157 (10 mg vial) 1.0 mg TB-500 (10 mg vial) 1.0 mg Spec Doses per vial (typical) BPC-157 (10 mg vial) ~2040 days TB-500 (10 mg vial) ~45 loading doses This separate-vial row keeps the same 10 mg-per-compound assumption as the 20 mg pre-blend, but the compounds are reconstituted and drawn independently